Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 090718

Expand all

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
12.5MG;7.5MG
Marketing Status: Prescription

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090718
Product Number: 001
Approval Date: Mar 17, 2010
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
12.5MG;15MG
Marketing Status: Prescription

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090718
Product Number: 002
Approval Date: Mar 17, 2010
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
25MG;15MG
Marketing Status: Prescription

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090718
Product Number: 003
Approval Date: Mar 17, 2010
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information